K292-1310 Screening compound: 4-(2-{[(7-hydroxy-2-oxo-2H-chromen-4-yl)methyl]sulfanyl}-4-oxo-3H,4H-thieno[3,2-d]pyrimidin-3-yl)-N-(2-phenylethyl)butanamide

K292-1310 Screening compound: 4-(2-{[(7-hydroxy-2-oxo-2H-chromen-4-yl)methyl]sulfanyl}-4-oxo-3H,4H-thieno[3,2-d]pyrimidin-3-yl)-N-(2-phenylethyl)butanamide
K292-1310 Screening compound: 4-(2-{[(7-hydroxy-2-oxo-2H-chromen-4-yl)methyl]sulfanyl}-4-oxo-3H,4H-thieno[3,2-d]pyrimidin-3-yl)-N-(2-phenylethyl)butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K292-1310
4-(2-{[(7-hydroxy-2-oxo-2H-chromen-4-yl)methyl]sulfanyl}-4-oxo-3H,4H-thieno[3,2-d]pyrimidin-3-yl)-N-(2-phenylethyl)butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K292-1310

Molecular Formula

C28H25N3O5S2 (C28 H25 N3 O5 S2)

Compound Name

4-(2-{[(7-hydroxy-2-oxo-2H-chromen-4-yl)methyl]sulfanyl}-4-oxo-3H,4H-thieno[3,2-d]pyrimidin-3-yl)-N-(2-phenylethyl)butanamide

IUPAC name

4-(2-{[(7-hydroxy-2-oxo-2H-chromen-4-yl)methyl]sulfanyl}-4-oxo-3H4H-thieno[32-d]pyrimidin-3-yl)-N-(2-phenylethyl)butanamide

SMILES

Oc(cc1)cc(O2)c1C(CSC(N(CCCC(NCCc1ccccc1)=O)C1=O)=Nc3c1scc3)=CC2=O

InChI

InChI=1S/C28H25N3O5S2/c32-20-8-9-21-19(15-25(34)36-23(21)16-20)17-38-28-30-22-11-14-37-26(22)27(35)31(28)13-4-7-24(33)29-12-10-18-5-2-1-3-6-18/h1-3,5-6,8-9,11,14-16,32H,4,7,10,12-13,17H2,(H,29,33)

InChI Key

LHWXRPODLBHIBB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15091786

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

547.66

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.884

Distribution Coefficient, logD

2.855

Water Solubility, LogSw

-3.63

Polar Surface Area

89.105

Acid Dissociation Constant (pKa)

8.56

Base Dissociation Constant (pKb)

0.72

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.40

K292-1310 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Eccentric PPI Library (11937 compounds)

Hsp90-Targeted Library (11355 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with K292-1310 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K292-1310?
Check Price and Availability of K292-1310, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K292-1310 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K292-1310
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K292-1310
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K292-1310 available by request